Singapore markets closed
Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.74 (-0.55%) Nasdaq
17,019.88 +99.08 (+0.59%) Bitcoin USD
67,916.05 -752.84 (-1.10%) CMC Crypto 200
1,462.89 -21.80 (-1.47%)
Lexeo Therapeutics, Inc. (LXEO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 15.46 |
| Open | 15.43 |
| Bid | 14.86 x 100 |
| Ask | 15.08 x 100 |
| Day's range | 14.53 - 15.43 |
| 52-week range | 9.00 - 22.33 |
| Volume | |
| Avg. volume | 133,868 |
| Market cap | 494.179M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
What Makes Lexeo Therapeutics, Inc. (LXEO) a New Buy Stock
Lexeo Therapeutics, Inc. (LXEO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks
Wall Street Analysts Think Lexeo Therapeutics, Inc. (LXEO) Could Surge 57.82%: Read This Before Placing a Bet
The mean of analysts' price targets for Lexeo Therapeutics, Inc. (LXEO) points to a 57.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- GuruFocus.com
Lexeo Therapeutics Inc (LXEO) Reports Q3 2023 Financial Results and Advances Clinical Programs
Key Clinical Trials Progress as IPO Strengthens Cash Reserves
© 2024 Yahoo. All rights reserved.